Gupta Gaurav, Maniker Allen
Department of Neurological Surgery, University of Medicine and Dentistry of New Jersey, Newark, New Jersey 07103, USA.
Neurosurg Focus. 2007 Jun 15;22(6):E12. doi: 10.3171/foc.2007.22.6.13.
Malignant peripheral nerve sheath tumors (MPNSTs) are rare soft tissue sarcomas of ectomesenchymal origin. The World Health Organization coined the term MPNST to replace previous heterogeneous and often confusing terminology, such as "malignant schwannoma," "malignant neurilemmoma," "neurogenic sarcoma," and "neurofibrosarcoma." Malignant peripheral nerve sheath tumors arise from major or minor peripheral nerve branches or sheaths of peripheral nerve fibers, and are derived from Schwann cells or pluripotent cells of neural crest origin. The Schwann cell is thought to be the major contributor to the formation of benign as well as malignant neoplasms of the nerve sheath. While this fact remains essentially true, the identity of cell of origin of the MPNST remains elusive, and has not yet been conclusively identified. It has been suggested that these tumors may have multiple cell line origins. In this review, the authors discuss the epidemiology, diagnosis, management, and treatment of MPNSTs.
恶性外周神经鞘瘤(MPNSTs)是一种罕见的起源于外胚间叶组织的软组织肉瘤。世界卫生组织创造了“MPNST”这个术语,以取代先前那些异质性且常常令人困惑的术语,如“恶性神经鞘瘤”“恶性神经膜瘤”“神经源性肉瘤”和“神经纤维肉瘤”。恶性外周神经鞘瘤起源于主要或次要的外周神经分支或外周神经纤维的鞘膜,由施万细胞或神经嵴来源的多能细胞衍生而来。施万细胞被认为是神经鞘良性和恶性肿瘤形成的主要贡献者。虽然这一事实基本属实,但MPNST的起源细胞身份仍然难以捉摸,尚未得到最终确定。有人提出这些肿瘤可能有多种细胞系起源。在这篇综述中,作者讨论了MPNST的流行病学、诊断、管理和治疗。